Clearside Biomedical, Inc. (CLSD) SEC filings
CLSD SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CLSD overview →
5 measured CLSD SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Clearside Biomedical, | SEC filing · Form 15-12G | +0.54% | -4.50% | |
| Form 8-K Clearside Biomedical, For: Dec 19 | SEC filing · Form 8-K | +20.55% | +27.16% | |
| Form EFFECT Clearside Biomedical, | SEC filing · Form EFFECT | +26.73% | -16.29% | |
| Form POS AM Clearside Biomedical, | SEC filing · Form POS | -3.85% | -3.85% | |
| Form S-8 POS Clearside Biomedical, | SEC filing · Form S-8 | -3.85% | -3.85% |
Keep exploring
More CLSD: earnings → · analyst actions → · CLSD overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Akari Therapeutics Plc - American Depositary Shares (AKTX) | 146 | 0.00% | 45% |
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 146 | 0.00% | 49% |
| Oramed Pharmaceuticals Inc. (ORMP) | 145 | +0.69% | 69% |
| GlycoMimetics, Inc. (GLYC) | 144 | +0.53% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.